Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer.
Katharina MöllerChristoph FrauneNiclas C BlessinMaximilian LennartzMartina KluthClaudia Hube-MaggLinnea LindhorstRoland DahlemMargit FischTill EichenauerSilke RiechardtRonald SimonGuido SauterFranziska BüscheckWolfgang HöppnerCord MatthiesOusman DohTill KrechAndreas H MarxHenrik ZechaMichael RinkStefan SteurerTill S ClauditzPublished in: International urology and nephrology (2021)
These data suggest that PD-L1 expression in highly immunogenic RCCs facilitates immune evasion and contributes to cancer aggressiveness.